Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer

Published:2009-02 Issue:2 Volume:90 Page:172-176
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Pryor David I.,Porceddu Sandro V.,Burmeister Bryan H.,Guminski Alex,Thomson Damien B.,Shepherdson Kristine,Poulsen Michael

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference20 articles.

1. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

2. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab;Curran;J Clin Oncol,2007

3. Homey B: severe cutaneous reaction during radiation therapy with concurrent cetuximab;Budach;N Engl J Med,2007

4. Acneiform rash secondary to cetuximab plus head and neck radiotherapy;Mydin;Radiother Oncol,2007

5. Severe skin reaction secondary to concomitant radiotherapy plus cetuximab;Berger;Radiat Oncol,2008

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment options for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma: a systematic review;Journal of Cancer Research and Clinical Oncology;2024-08-02

2. Recent advances in cancer therapy‐associated oral mucositis;Oral Diseases;2024-07-05

3. Radiation dermatitis in the hairless mouse model mimics human radiation dermatitis;2024-05-23

4. Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC;Scientific Reports;2024-02-14

5. Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2);International Journal of Clinical Oncology;2022-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3